Biora Therapeutics Inc (BIOR)

$0.66

-0.04

(-5.89%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $0.66
    $0.71
    $0.66
    downward going graph

    0.0%

    Downside

    Day's Volatility :7.04%

    Upside

    7.04%

    downward going graph
  • $0.48
    $3.98
    $0.66
    downward going graph

    28.03%

    Downside

    52 Weeks Volatility :88.07%

    Upside

    83.42%

    downward going graph

Returns

PeriodBiora Therapeutics IncIndex (Russel 2000)
3 Months
8.89%
0.0%
6 Months
-26.24%
0.0%
1 Year
-82.77%
0.0%
3 Years
-96.53%
-19.6%

Highlights

Market Capitalization
25.2M
Book Value
- $3.29
Earnings Per Share (EPS)
-6.43
Wall Street Target Price
10.3
Profit Margin
0.0%
Operating Margin TTM
-2862.73%
Return On Assets TTM
-110.05%
Return On Equity TTM
0.0%
Revenue TTM
544.0K
Revenue Per Share TTM
0.03
Quarterly Revenue Growth YOY
27000.0%
Gross Profit TTM
1.2M
EBITDA
-66.6M
Diluted Eps TTM
-6.43
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.64
EPS Estimate Next Year
-1.27
EPS Estimate Current Quarter
-0.45
EPS Estimate Next Quarter
-0.46

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Biora Therapeutics Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 1460.61%

Current $0.66
Target $10.30

Technicals Summary

Sell

Neutral

Buy

Biora Therapeutics Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Biora Therapeutics Inc
Biora Therapeutics Inc
-4.38%
-26.24%
-82.77%
-96.53%
-96.53%
Moderna, Inc.
Moderna, Inc.
-11.58%
21.5%
-1.52%
-62.55%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.03%
12.81%
46.27%
81.23%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-7.55%
24.69%
62.32%
198.21%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.5%
11.69%
37.68%
150.78%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Biora Therapeutics Inc
Biora Therapeutics Inc
NA
NA
NA
-1.64
0.0
-1.1
NA
-3.29
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Biora Therapeutics Inc
Biora Therapeutics Inc
Buy
$25.2M
-96.53%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Biora Therapeutics Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 2.0K → 872.0K (in $), with an average increase of 99.8% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -73.45M → -15.41M (in $), with an average increase of 188.3% per quarter

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 58.8% return, outperforming this stock by 141.6%

Institutional Holdings

  • Athyrium Capital Management LP

    30.46%
  • Vanguard Group Inc

    1.61%
  • Geode Capital Management, LLC

    0.56%
  • Northern Trust Corp

    0.19%
  • BlackRock Inc

    0.18%
  • State Street Corporation

    0.09%

Company Information

progenity helps patients and their families prepare for life, with medically relevant health information starting before conception, through pregnancy, childhood, and adulthood. using our highly-complex molecular diagnostic testing, healthcare providers can access the most advanced genomic technology to guide patient care at critical life stages.

Organization
Biora Therapeutics Inc
Employees
58
CEO
Mr. Aditya P. Mohanty M.B.A.
Industry
Miscellaneous

FAQs